Timing Matters: Circadian Effects on Energy Homeostasis and Alzheimer’s Disease

Trends in Endocrinology & Metabolism - Tập 30 Số 2 - Trang 132-143 - 2019
Aline Loehfelm1,2, Alisa Boucsein1,2, Dominik Pretz1,2, Alexander Tups1
1Centre for Neuroendocrinology and Brain Health Research Centre, Department of Physiology, School of Medical Sciences, University of Otago, Dunedin 9054, New Zealand
2these authors contributed equally to this work

Tóm tắt

Từ khóa


Tài liệu tham khảo

International Diabetes Federation. About diabetes. https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.

World Health Organization. Obesity and overweight. http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Bernard, 1854

Woods, 1979, Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons, Nature, 282, 503, 10.1038/282503a0

Bruning, 2000, Role of brain insulin receptor in control of body weight and reproduction, Science, 289, 2122, 10.1126/science.289.5487.2122

Pocai, 2005, Hypothalamic K(ATP) channels control hepatic glucose production, Nature, 434, 1026, 10.1038/nature03439

Obici, 2002, Hypothalamic insulin signaling is required for inhibition of glucose production, Nat. Med., 8, 1376, 10.1038/nm1202-798

Abraham, 2014, Insulin action in the hypothalamus and dorsal vagal complex, Exp. Physiol., 99, 1104, 10.1113/expphysiol.2014.079962

Kahn, 1993, Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function, Diabetes, 42, 1663, 10.2337/diab.42.11.1663

Feve, 2006, Relationship between obesity, inflammation and insulin resistance: new concepts, C R Biol., 329, 587

Knight, 2010, Hyperleptinemia is required for the development of leptin resistance, PLoS One, 5, 10.1371/journal.pone.0011376

Frank-Podlech, 2018, Leptin replacement reestablishes brain insulin action in the hypothalamus in congenital leptin deficiency, Diabetes Care, 41, 907, 10.2337/dc17-1867

Koch, 2010, Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity, J. Neurosci., 30, 16180, 10.1523/JNEUROSCI.3202-10.2010

Benzler, 2012, Hypothalamic glycogen synthase kinase 3beta has a central role in the regulation of food intake and glucose metabolism, Biochem. J., 447, 175, 10.1042/BJ20120834

Inestrosa, 2010, Emerging roles of Wnts in the adult nervous system, Nat. Rev. Neurosci., 11, 77, 10.1038/nrn2755

Benzler, 2013, Hypothalamic WNT signalling is impaired during obesity and reinstated by leptin treatment in male mice, Endocrinology, 154, 4737, 10.1210/en.2013-1746

McEwen, 2018, Feeding and GLP-1 receptor activation stabilize beta-catenin in specific hypothalamic nuclei in male rats, J. Neuroendocrinol., 30, 10.1111/jne.12607

MacDonald, 2009, Wnt/beta-catenin signaling: components, mechanisms, and diseases, Dev. Cell, 17, 9, 10.1016/j.devcel.2009.06.016

Boucsein, 2016, Photoperiodic and diurnal regulation of WNT signaling in the arcuate nucleus of the female Djungarian hamster: Phodopus sungorus, Endocrinology, 157, 799, 10.1210/en.2015-1708

Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485

Benzler, 2015, Central inhibition of IKKbeta/NF-kappaB signaling attenuates high-fat diet-induced obesity and glucose intolerance, Diabetes, 64, 2015, 10.2337/db14-0093

Purkayastha, 2013, Neuroinflammatory basis of metabolic syndrome, Mol. Metab., 2, 356, 10.1016/j.molmet.2013.09.005

Zhang, 2008, Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity, Cell, 135, 61, 10.1016/j.cell.2008.07.043

Ramsey, 2007, The clockwork of metabolism, Annu. Rev. Nutr., 27, 219, 10.1146/annurev.nutr.27.061406.093546

Coomans, 2013, The suprachiasmatic nucleus controls circadian energy metabolism and hepatic insulin sensitivity, Diabetes, 62, 1102, 10.2337/db12-0507

Marcheva, 2010, Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes, Nature, 466, 627, 10.1038/nature09253

Turek, 2005, Obesity and metabolic syndrome in circadian clock mutant mice, Science, 308, 1043, 10.1126/science.1108750

Perelis, 2015, Pancreatic beta cell enhancers regulate rhythmic transcription of genes controlling insulin secretion, Science, 350, 10.1126/science.aac4250

Roenneberg, 2012, Social jetlag and obesity, Curr. Biol., 22, 939, 10.1016/j.cub.2012.03.038

Scheer, 2009, Adverse metabolic and cardiovascular consequences of circadian misalignment, Proc. Natl. Acad. Sci. U. S. A., 106, 4453, 10.1073/pnas.0808180106

Leproult, 2014, Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss, Diabetes, 63, 1860, 10.2337/db13-1546

Kettner, 2015, Circadian dysfunction induces leptin resistance in mice, Cell Metab., 22, 448, 10.1016/j.cmet.2015.06.005

Pendergast, 2013, High-fat diet acutely affects circadian organisation and eating behavior, Eur. J. Neurosci., 37, 1350, 10.1111/ejn.12133

Kohsaka, 2007, High-fat diet disrupts behavioral and molecular circadian rhythms in mice, Cell Metab., 6, 414, 10.1016/j.cmet.2007.09.006

Scheiermann, 2013, Circadian control of the immune system, Nat. Rev. Immunol., 13, 190, 10.1038/nri3386

Gibbs, 2012, The nuclear receptor REV-ERBalpha mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines, Proc. Natl. Acad. Sci. U. S. A., 109, 582, 10.1073/pnas.1106750109

Narasimamurthy, 2012, Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines, Proc. Natl. Acad. Sci. U. S. A., 109, 12662, 10.1073/pnas.1209965109

Spengler, 2012, Core circadian protein CLOCK is a positive regulator of NF-kappaB-mediated transcription, Proc. Natl. Acad. Sci. U. S. A., 109, E2457, 10.1073/pnas.1206274109

Li, 2012, Leptin-sensitive neurons in the arcuate nuclei contribute to endogenous feeding rhythms, Am. J. Physiol. Regul. Integr. Comp. Physiol., 302, R1313, 10.1152/ajpregu.00086.2012

Tan, 2014, Ablation of AgRP neurons impairs adaption to restricted feeding, Mol. Metab., 3, 694, 10.1016/j.molmet.2014.07.002

Rutter, 2001, Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors, Science, 293, 510, 10.1126/science.1060698

Asher, 2008, SIRT1 regulates circadian clock gene expression through PER2 deacetylation, Cell, 134, 317, 10.1016/j.cell.2008.06.050

Schug, 2011, Sirtuin 1 in lipid metabolism and obesity, Ann. Med., 43, 198, 10.3109/07853890.2010.547211

Chaix, 2014, Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges, Cell Metab., 20, 991, 10.1016/j.cmet.2014.11.001

Hatori, 2012, Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet, Cell Metab., 15, 848, 10.1016/j.cmet.2012.04.019

Longo, 2014, Fasting: molecular mechanisms and clinical applications, Cell Metab., 19, 181, 10.1016/j.cmet.2013.12.008

Sherman, 2012, Timed high-fat diet resets circadian metabolism and prevents obesity, FASEB J., 26, 3493, 10.1096/fj.12-208868

Kametani, 2018, Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer’s disease, Front. Neurosci., 12, 25, 10.3389/fnins.2018.00025

Heppner, 2015, Immune attack: the role of inflammation in Alzheimer disease, Nat. Rev. Neurosci., 16, 358, 10.1038/nrn3880

Huang, 2017, TLR4 is a link between diabetes and Alzheimer’s disease, Behav. Brain Res., 316, 234, 10.1016/j.bbr.2016.08.047

Zhao, 2014, The role of TLR4-mediated PTEN/PI3K/AKT/NF-kappaB signaling pathway in neuroinflammation in hippocampal neurons, Neuroscience, 269, 93, 10.1016/j.neuroscience.2014.03.039

Steen, 2005, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease −is this type 3 diabetes?, J. Alzheimers Dis., 7, 63, 10.3233/JAD-2005-7107

Gray, 2014, Insulin regulates brain function, but how does it get there?, Diabetes, 63, 3992, 10.2337/db14-0340

Talbot, 2012, Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline, J. Clin. Invest., 122, 1316, 10.1172/JCI59903

Rivera, 2005, Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine, J. Alzheimers Dis., 8, 247, 10.3233/JAD-2005-8304

Butterfield, 2014, Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain, Biochim. Biophys. Acta, 1842, 1693, 10.1016/j.bbadis.2014.06.010

Willette, 2015, Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease, JAMA Neurol., 72, 1013, 10.1001/jamaneurol.2015.0613

Marcus, 2014, Brain PET in the diagnosis of Alzheimer’s disease, Clin. Nucl. Med., 39, 10.1097/RLU.0000000000000547

Vandal, 2015, Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer’s disease, FASEB J., 29, 4273, 10.1096/fj.14-268482

Niccoli, 2016, Increased glucose transport into neurons rescues abeta toxicity in Drosophila, Curr. Biol., 26, 2550, 10.1016/j.cub.2016.09.018

de la Monte, 2011, si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder, Mol. Brain, 4, 13, 10.1186/1756-6606-4-13

Grunblatt, 2007, Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein, J. Neurochem., 101, 757, 10.1111/j.1471-4159.2006.04368.x

Watson, 2003, Insulin increases CSF Abeta42 levels in normal older adults, Neurology, 60, 1899, 10.1212/01.WNL.0000065916.25128.25

Yamamoto, 2018, Insulin-signaling pathway regulates the degradation of amyloid beta-protein via astrocytes, Neuroscience, 385, 227, 10.1016/j.neuroscience.2018.06.018

Ma, 2009, Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin, J. Neurosci., 29, 9078, 10.1523/JNEUROSCI.1071-09.2009

Hanger, 1992, Glycogen synthase kinase-3 induces Alzheimer’s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase, Neurosci. Lett., 147, 58, 10.1016/0304-3940(92)90774-2

Reger, 2006, Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype, Neurobiol. Aging., 27, 451, 10.1016/j.neurobiolaging.2005.03.016

Reger, 2008, Intranasal insulin improves cognition and modulates beta-amyloid in early AD, Neurology, 70, 440, 10.1212/01.WNL.0000265401.62434.36

Cao, 2018, DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer’s disease, Eur. J. Pharmacol., 827, 215, 10.1016/j.ejphar.2018.03.024

Batista, 2018, The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer’s disease, J. Pathol., 245, 85, 10.1002/path.5056

McClean, 2011, The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease, J. Neurosci., 31, 6587, 10.1523/JNEUROSCI.0529-11.2011

Kondratov, 2006, Early aging and age-related pathologies in mice deficient in BMAL1: the core component of the circadian clock, Genes Dev., 20, 1868, 10.1101/gad.1432206

Krishnan, 2009, The circadian clock gene period extends healthspan in aging Drosophila melanogaster, Aging (Albany NY), 1, 937, 10.18632/aging.100103

Mattis, 2016, Circadian rhythms, sleep, and disorders of aging, Trends Endocrinol. Metab., 27, 192, 10.1016/j.tem.2016.02.003

Merlino, 2010, Daytime sleepiness is associated with dementia and cognitive decline in older Italian adults: a population-based study, Sleep Med., 11, 372, 10.1016/j.sleep.2009.07.018

Weissova, 2016, Moderate changes in the circadian system of Alzheimer’s disease patients detected in their home environment, PLoS One, 11, 10.1371/journal.pone.0146200

Waller, 2016, Melatonin and cortisol profiles in late midlife and their association with age-related changes in cognition, Nat. Sci. Sleep, 8, 47

Wu, 2003, Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages, J. Clin. Endocrinol. Metab., 88, 5898, 10.1210/jc.2003-030833

Satlin, 1995, Circadian locomotor activity and core-body temperature rhythms in Alzheimer’s disease, Neurobiol. Aging, 16, 765, 10.1016/0197-4580(95)00059-N

Wu, 2007, Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease, Neurobiol. Aging, 28, 1239, 10.1016/j.neurobiolaging.2006.06.002

Wu, 2006, Pineal clock gene oscillation is disturbed in Alzheimer’s disease, due to functional disconnection from the master clock, FASEB J., 20, 1874, 10.1096/fj.05-4446fje

Belanger, 2006, The circadian regulation of Presenilin-2 gene expression, Chronobiol. Int., 23, 747, 10.1080/07420520600827087

Schmitt, 2017, Amyloid-beta-induced changes in molecular clock properties and cellular bioenergetics, Front. Neurosci., 11, 124, 10.3389/fnins.2017.00124

Kress, 2018, Regulation of amyloid-beta dynamics and pathology by the circadian clock, J. Exp. Med., 215, 1059, 10.1084/jem.20172347

Hood, 2017, Neurodegeneration and the circadian clock, Front. Aging. Neurosci., 9, 170, 10.3389/fnagi.2017.00170

Forbes, 2016, Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia, Cochrane Database Syst. Rev., 2014

McCurry, 2011, Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: results of a randomized, controlled trial, J. Am. Geriatr. Soc., 59, 1393, 10.1111/j.1532-5415.2011.03519.x

Gehrman, 2009, Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease, Am. J. Geriatr. Psychiatry, 17, 166, 10.1097/JGP.0b013e318187de18

Riemersma-van der Lek, 2008, Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial, JAMA, 299, 2642, 10.1001/jama.299.22.2642

Lopez, 2008, Clinical symptoms in Alzheimer’s disease, Handb. Clin. Neurol., 89, 207, 10.1016/S0072-9752(07)01219-5

Fandos, 2017, Plasma amyloid beta 42/40 ratios as biomarkers for amyloid beta cerebral deposition in cognitively normal individuals, Alzheimers Dement. (Amst), 8, 179, 10.1016/j.dadm.2017.07.004

Chen, 2007, RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer’s disease, Curr. Mol. Med., 7, 735, 10.2174/156652407783220741

Tonnies, 2017, Oxidative stress, synaptic dysfunction, and Alzheimer’s disease, J. Alzheimers Dis., 57, 1105, 10.3233/JAD-161088

Hornberger, 2017, Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer’s disease −the case of florbetapir, Curr. Med. Res. Opin., 33, 675, 10.1080/03007995.2016.1277197

Nakamura, 2018, High performance plasma amyloid-beta biomarkers for Alzheimer’s disease, Nature, 554, 249, 10.1038/nature25456

Ott, 1999, Diabetes mellitus and the risk of dementia: The Rotterdam Study, Neurology, 53, 1937, 10.1212/WNL.53.9.1937